Lataa...
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
Estrogen receptor α (ER) is the major driver of ∼75% of breast cancers, and multiple ER targeting drugs are routinely used clinically to treat patients with ER(+) breast cancer. However, many patients relapse on these targeted therapies and ultimately develop metastatic and incurable disease, and un...
Tallennettuna:
| Julkaisussa: | Genes Dev |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cold Spring Harbor Laboratory Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120708/ https://ncbi.nlm.nih.gov/pubmed/30181360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.316646.118 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|